“Find something they enjoy and use that to get them active,” said April L. Hartman, MD, the Hahn Endowed Chair in Pediatrics at the Medical College of Georgia at Augusta University.
The first in-human study of a new immunotherapy that blocks a natural enzyme that tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life...